SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Jagsonpal Pharmaceuticals to acquire India business of Resilient Cosmeceuticals

22 Feb 2025 Evaluate

Jagsonpal Pharmaceuticals has signed a Business Transfer Agreement to acquire the India business of Resilient Cosmeceuticals for a cash consideration of Rs 24 crore, to be funded from internal accruals. The company had a cash balance of Rs 132 crore as on December 31, 2024. 

The transaction is subject to customary closing conditions and is expected to close within 45 days. The acquisition gives access to a complimentary portfolio of Pharmaceuticals, Nutritional and Cosmetic products tapping into around Rs 1000 crore market opportunity in India.

Jagsonpal Pharmaceuticals is among India’s premiere pharmaceutical companies. The company has substantial research and development, manufacturing, marketing and distribution facilities. 


Jagsonpal Pharma Share Price

194.05 -0.40 (-0.21%)
16-Apr-2026 15:47 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1693.15
Dr. Reddys Lab 1221.25
Cipla 1230.75
Zydus Lifesciences 938.00
Lupin 2322.70
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×